Cargando…

Gut microbiota composition is associated with narcolepsy type 1

OBJECTIVE: To test the hypothesis that narcolepsy type 1 (NT1) is related to the gut microbiota, we compared the microbiota bacterial communities of patients with NT1 and control subjects. METHODS: Thirty-five patients with NT1 (51.43% women, mean age 38.29 ± 19.98 years) and 41 controls (57.14% wom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lecomte, Alexandre, Barateau, Lucie, Pereira, Pedro, Paulin, Lars, Auvinen, Petri, Scheperjans, Filip, Dauvilliers, Yves
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577550/ https://www.ncbi.nlm.nih.gov/pubmed/33037102 http://dx.doi.org/10.1212/NXI.0000000000000896

Ejemplares similares

Recent advances in treatment for narcolepsy
por: Barateau, Lucie, et al.
Publicado: (2019)

Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression
por: Aho, Velma T.E., et al.
Publicado: (2019)

Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson’s disease
por: Pereira, Pedro A. B., et al.
Publicado: (2022)

Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease
por: Aho, Velma T. E., et al.
Publicado: (2021)

Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy
por: Lopez, Régis, et al.
Publicado: (2017)

[18F]Fludeoxyglucose-Positron Emission Tomography Evidence for Cerebral Hypermetabolism in the Awake State in Narcolepsy and Idiopathic Hypersomnia
por: Dauvilliers, Yves, et al.
Publicado: (2017)

CSF and serum ferritin levels in narcolepsy type 1 comorbid with restless legs syndrome
por: Barateau, Lucie, et al.
Publicado: (2020)

Absence of NMDA receptor antibodies in the rare association between Type 1 Narcolepsy and Psychosis
por: Dauvilliers, Y., et al.
Publicado: (2016)

Cerebrospinal fluid proteomics in recent-onset Narcolepsy type 1 reveals activation of the complement system
por: Ayoub, Ikram, et al.
Publicado: (2023)

Gut Microbiota in Patients with Type 1 Narcolepsy
por: Zhang, Ruirui, et al.
Publicado: (2021)

Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2021)

Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning
por: Zhang, Zhongxing, et al.
Publicado: (2018)

Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study
por: Dauvilliers, Yves, et al.
Publicado: (2019)

Executive Control of Attention in Narcolepsy
por: Bayard, Sophie, et al.
Publicado: (2012)

Reward-based behaviors and emotional processing in human with narcolepsy-cataplexy
por: Bayard, Sophie, et al.
Publicado: (2013)

Low Vitamin D in Narcolepsy with Cataplexy
por: Carlander, Bertrand, et al.
Publicado: (2011)

Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia
por: Pereira, Pedro, et al.
Publicado: (2017)

Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy
por: Dauvilliers, Yves A., et al.
Publicado: (2014)

Differences in Brain Morphological Findings between Narcolepsy with and without Cataplexy
por: Nakamura, Masaki, et al.
Publicado: (2013)

Non-Dipping Blood Pressure Profile in Narcolepsy with Cataplexy
por: Dauvilliers, Yves, et al.
Publicado: (2012)

Increased Immune Complexes of Hypocretin Autoantibodies in Narcolepsy
por: Deloumeau, Aude, et al.
Publicado: (2010)

Neural network analysis of sleep stages enables efficient diagnosis of narcolepsy
por: Stephansen, Jens B., et al.
Publicado: (2018)

Histamine in murine narcolepsy: What do genetic and immune models tell us?
por: Melzi, Silvia, et al.
Publicado: (2021)

Idling for Decades: A European Study on Risk Factors Associated with the Delay Before a Narcolepsy Diagnosis
por: Zhang, Zhongxing, et al.
Publicado: (2022)

Molecular analysis of meso- and thermophilic microbiota associated with anaerobic biowaste degradation
por: Ritari, Jarmo, et al.
Publicado: (2012)

Clinical and polysomnographic course of childhood narcolepsy with cataplexy
por: Pizza, Fabio, et al.
Publicado: (2013)

A randomized study of solriamfetol for excessive sleepiness in narcolepsy
por: Thorpy, Michael J., et al.
Publicado: (2019)

Narcolepsy with cataplexy: Does age at diagnosis change the clinical picture?
por: Zhang, Min, et al.
Publicado: (2020)

Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy
por: Ollila, Hanna M., et al.
Publicado: (2023)

Narcolepsy type 1
por: Swarnakar, Rajesh, et al.
Publicado: (2019)

Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial
por: Dauvilliers, Yves, et al.
Publicado: (2023)

Subgingival microbiota in a population with and without cognitive dysfunction
por: Holmer, Jacob, et al.
Publicado: (2021)

The Gut and Parkinson’s Disease: Hype or Hope?
por: Scheperjans, Filip, et al.
Publicado: (2018)

Complex movement disorders at disease onset in childhood narcolepsy with cataplexy
por: Plazzi, Giuseppe, et al.
Publicado: (2011)

Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson’s Disease: A Systematic Review
por: Boertien, Jeffrey M., et al.
Publicado: (2019)

Application of hybridization control probe to increase accuracy on ligation detection or minisequencing diagnostic microarrays
por: Ritari, Jarmo, et al.
Publicado: (2009)

High-dimensional single-cell analysis reveals the immune signature of narcolepsy
por: Hartmann, Felix J., et al.
Publicado: (2016)

Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution: A Lower-Sodium Alternative for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy
por: Dauvilliers, Yves, et al.
Publicado: (2022)

Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
por: Boertien, Jeffrey M., et al.
Publicado: (2022)

Cardiac Sympathetic Activity differentiates Idiopathic and Symptomatic Rapid Eye Movement Sleep Behaviour Disorder
por: Barateau, Lucie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_os3sofnhoaum4nddb1mpsk9osi